Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Epoetin Beta

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 6Mircera

    02 1NeoRecormon

    03 4NeoRecormon/Epogin

    04 2Neorecormon/Epogin

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : NeoRecormon/Epogin

    Methoxy Polyethylene Glycol-Epoetin Beta

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : NeoRecormon/Epogin

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Methoxy Polyethylene Glycol-Epoetin Beta

    Main Therapeutic Indication : Hematology

    Currency : USD

    2019 Revenue in Millions : 270

    2018 Revenue in Millions : 297

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Mircera

    Methoxy Polyethylene Glycol-Epoetin Beta

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : Mircera

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Methoxy Polyethylene Glycol-Epoetin Beta

    Main Therapeutic Indication : Hematology

    Currency : USD

    2019 Revenue in Millions : 609

    2018 Revenue in Millions : 548

    Growth (%) : 11

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Mircera

    Methoxy Polyethylene Glycol-Epoetin Beta

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : Mircera

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Methoxy Polyethylene Glycol-Epoetin Beta

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 524

    2019 Revenue in Millions : 658

    Growth (%) : -20

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : NeoRecormon/Epogin

    Methoxy Polyethylene Glycol-Epoetin Beta

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : NeoRecormon/Epogin

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Methoxy Polyethylene Glycol-Epoetin Beta

    Main Therapeutic Indication : Hematology

    Currency : USD

    2020 Revenue in Millions : 266

    2019 Revenue in Millions : 292

    Growth (%) : -9

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Mircera

    Methoxy Polyethylene Glycol and Epoetin Beta

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : Mircera

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Methoxy Polyethylene Glycol and Epoetin Beta

    Main Therapeutic Indication : Hematology

    Currency : USD

    2021 Revenue in Millions : 468

    2020 Revenue in Millions : 498

    Growth (%) : -7

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Mircera

    Methoxy Polyethylene Glycol-Epoetin Beta

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : Mircera

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Methoxy Polyethylene Glycol-Epoetin Beta

    Main Therapeutic Indication : Hematology

    Currency : USD

    2022 Revenue in Millions : 446

    2021 Revenue in Millions : 468

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Mircera

    Methoxy Polyethylene Glycol-Epoetin Beta

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : Mircera

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Methoxy Polyethylene Glycol-Epoetin Beta

    Main Therapeutic Indication : Hematology

    Currency : USD

    2023 Revenue in Millions : 494

    2022 Revenue in Millions : 446

    Growth (%) : 4

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : NeoRecormon

    Epoetin Beta, Epoetin Alfa

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : NeoRecormon

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Epoetin Beta, Epoetin Alfa

    Main Therapeutic Indication : Blood Related Disorders

    Currency : USD

    2014 Revenue in Millions : -11.50%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : NeoRecormon/Epogin

    Epoetin Beta, Epoetin Alfa

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : NeoRecormon/Epogin

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Epoetin Beta, Epoetin Alfa

    Main Therapeutic Indication : Blood Related Disorders

    Currency : USD

    2015 Revenue in Millions : 465

    2014 Revenue in Millions : 370

    Growth (%) : -20%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Neorecormon/Epogin

    Epoetin Beta, Epoetin Alfa

    arrow
    International Sweetener Colloquium
    Not Confirmed

    Brand Name : Neorecormon/Epogin

    Switzerland
    arrow
    International Sweetener Colloquium
    Not Confirmed

    Roche

    Epoetin Beta, Epoetin Alfa

    Main Therapeutic Indication : Blood Disorders

    Currency : USD

    2016 Revenue in Millions : 325

    2015 Revenue in Millions : 362

    Growth (%) : -10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.